Headlines Covid-19 Specialties Trending Feeds Videos

Pfizer-BioNTech Evaluating Third COVID-19 Vaccine Dose for Variants

posted 2 days


Mashup Score: 230

Contagion Live - The new trial comes at a time when the FDA has provided guidance on navigating immunogenicity trials for vaccines designed against more transmissible SARS-CoV-2...

  • A variant booster? Pfizer and BioNTech has launched a safety and immunogenicity assessment for a 3rd dose of its #COVID19 vaccine BNT162b2 to consider a booster intended to provide immunity to circulating potentially new #SARSCoV2 variants. https://t.co/gBbghaB8xx

RA Monoclonal Antibody Does Not Meet Primary Endpoint In COVID-19 Pneumonia Patients

posted 2 days


Mashup Score: 36

Contagion Live - In a phase 3 study, rheumatoid arthritis (RA) therapy, tocilizumab, did not improve clinical status or lower mortality in these...

  • In a phase 3 study, #rheumatoidarthritis therapy #tocilizumab did not improve clinical status or lower mortality in these patients. #COVID19 https://t.co/T3PjCwnQ0O

SOFA Score Insufficient for Predicting COVID-19 Mortality Before Intubation

posted 2 days


Mashup Score: 7

Contagion Live - A better option is needed that can incorporate specific mortality-related variables, the study authors...

FDA’s VRBPAC Meeting to Discuss Efficacy of Janssen COVID-19 Vaccine

posted 16 hours


Mashup Score: 7

Contagion Live - This would be the first one-shot vaccine looking at potential Emergency Use Authorization (EUA) in the United...

  • Breaking: The FDA's Vaccines and Related Biologic Products Advisory Committee has voted to support the benefits of Janssen Pharmaceutical's one-shot #COVID19 vaccine against its risks. Authorization is likely imminent for a third pandemic vaccine. https://t.co/TNbIM7fIFC

Canada Authorizes AstraZeneca’s COVID-19 Vaccine

posted 20 hours


Mashup Score: 2

Contagion Live - The country has no domestic production, and the government has been accused of not acquiring doses quickly...

Children Not Super Spreaders of SARS-CoV-2

posted 2 days


Mashup Score: 1

Contagion Live - Study results highlight that new data is constantly emerging and that society must be flexible in its response to the...

RA Monoclonal Antibody Does Not Meet Primary Endpoint In COVID-19 Pneumonia Patients

posted 23 hours


Contagion Live - In a phase 3 study, rheumatoid arthritis (RA) therapy, tocilizumab, did not improve clinical status or lower mortality in these...

  • “We did not find significant improvement in clinical status, the designated primary endpoint for the study. However, our findings suggest that duration of hospitalization and the need for ICU ventilatory support may be improved with #tocilizumab ." https://t.co/T3PjCwFqSm

Over Half of COVID-19 Hospitalizations Due to 4 Conditions

posted 23 hours


Contagion Live - Patients with cardiometabolic conditions have a high risk of poor...

  • "Medical providers should educate patients who may be at risk for severe #COVID19 and consider promoting preventive lifestyle measures." https://t.co/YuEyD6SxT5

Minorities Are Underrepresented in Vaccine Clinical Trials

posted 22 hours


Contagion Live - Vaccine clinical trials have fallen short of diversity guidelines during the past decade, with minority groups underrepresented and key data missing in many trials,...

Minorities Are Underrepresented in Vaccine Clinical Trials

posted 2 days


Contagion Live - Vaccine clinical trials have fallen short of diversity guidelines during the past decade, with minority groups underrepresented and key data missing in many trials,...